Healthcare private equity firm raises nearly US$500m for Asia healthcare fund

The fund will attract both existing and new investors.

Quadria Capital, one of Asia’s healthcare-focused private equity firms, revealed that it held a first close for its third healthcare fund at over 60% of the target fund size. 

With this first close, Fund III is more than halfway to reaching its target fund size of US$800m. 

The fund will be used to continue commitments that have come from both existing and new investors including institutional investors, insurance and pension funds, development finance institutions and family offices across the US, Europe and Asia-Pacific. 

The fund will continue to invest in large, scalable, market-leading businesses in South and Southeast Asia with the potential to generate financial returns whilst making a social impact on the communities they serve.
 
Aside from this fund, the firm also agreed to invest up to US$155m in Maxivision Eye Hospital, one of India’s leading and fastest-growing private eyecare clinics. 

“The first tranche of roughly US$75m gives Quadria a significant minority stake and a further investment of up to US$80m would give it a controlling interest,” read the statement.

This investment and Quadria’s support will back Maxivision’s ability to expand the scale of its business and serve the increasing demand for eye care in underserved South and West Indian cities.